Back to Trades
Other4
Moderna, Inc.
MRNA
Total Value
$2.3M
Company Information
- Company Name
- Moderna, Inc.
- Ticker Symbol
- MRNA
- CIK
- 0001682852
Insider Information
- Name
- Mock James M
- Role
- Chief Financial Officer
- Location
- CAMBRIDGE, MA
Officer
Filing Details
- Filing Date
- Mar 3, 2026
- Transaction Date
- Feb 27, 2026
- Accession Number
- 0001682852-26-000038
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | 329 | — | Exercise | — |
| Feb 27, 2026 | Common Stock | 160 | $51.71 | Tax Withholding | $8.3K |
| Feb 27, 2026 | Common Stock | 774 | — | Exercise | — |
| Feb 27, 2026 | Common Stock | 375 | $51.71 | Tax Withholding | $19.4K |
| Feb 27, 2026 | Common Stock | 9,901 | — | Exercise | — |
| Feb 27, 2026 | Common Stock | 4,788 | $51.71 | Tax Withholding | $247.6K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Derivative | 329 | — | Exercise | — |
| Feb 27, 2026 | Derivative | 774 | — | Exercise | — |
| Feb 27, 2026 | Derivative | 9,901 | — | Exercise | — |
| Mar 1, 2026 | Derivative | 37,639 | $53.57 | Grant/Award | $2.0M |
| Mar 1, 2026 | Derivative | 49,569 | — | Grant/Award | — |
Footnotes
- (F1)Restricted stock units convert into common stock on a one-for-one basis.
- (F2)Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- (F3)25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- (F4)25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- (F5)25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- (F6)25% of this option will vest and become exercisable on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- (F7)25% of the shares subject to this restricted stock unit award will vest on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.